journal
Journals Current Opinion in Organ Trans...

Current Opinion in Organ Transplantation

https://read.qxmd.com/read/38205868/bacterial-infections-in-solid-organ-transplant-recipients
#21
JOURNAL ARTICLE
Johan Courjon, Dionysios Neofytos, Christian van Delden
PURPOSE OF REVIEW: Bacteria are the leading cause of infections in solid organ transplant (SOT) recipients, significantly impacting patient outcome. Recently detailed and comprehensive epidemiological data have been published. RECENT FINDING: This literature review aims to provide an overview of bacterial infections affecting different types of SOT recipients, emphasizing underlying risk factors and pathophysiological mechanisms. SUMMARY: Lung transplantation connects two microbiotas: one derived from the donor's lower respiratory tract with one from the recipient's upper respiratory tract...
January 12, 2024: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/38088373/advances-in-desensitization-for-human-leukocyte-antigen-incompatible-kidney-transplantation
#22
JOURNAL ARTICLE
Ashley Vo, Noriko Ammerman, Stanley C Jordan
PURPOSE OF REVIEW: Human leukocyte antigen (HLA) sensitization is a major barrier to kidney transplantation induced by exposure to alloantigens through pregnancy, blood product exposure and previous transplantations. Desensitization strategies are undertaken to improve the chances of finding compatible organ offers. Standard approaches to desensitization include the use of plasmapheresis/low dose intravenous immunoglobulin (IVIG) or high dose IVIG plus anti-CD20. However, current methods to reduce HLA antibodies are not always successful, especially in those with calculated panel reactive antibody 99-100%...
December 14, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/38038621/molecular-profiling-in-the-management-of-hepatocellular-carcinoma
#23
JOURNAL ARTICLE
Nadine Soliman, Ashish Saharia, Maen Abdelrahim, Ashton A Connor
PURPOSE OF REVIEW: The purpose of this review is to both summarize the current knowledge of hepatocellular carcinoma molecular biology and to suggest a framework in which to prospectively translate this knowledge into patient care. This is timely as recent guidelines recommend increased use of these technologies to advance personalized liver cancer care. RECENT FINDINGS: The main themes covered here address germline and somatic genetic alterations recently discovered in hepatocellular carcinoma, largely owing to next generation sequencing technologies, and nascent efforts to translate these into contemporary practice...
December 4, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/38032262/emerging-phenotypes-in-kidney-transplant-rejection
#24
JOURNAL ARTICLE
Michael Mengel, Benjamin A Adam
PURPOSE OF REVIEW: This review focuses on more recently emerging rejection phenotypes in the context of time post transplantation and the resulting differential diagnostic challenges. It also discusses how novel ancillary diagnostic tools can potentially increase the accuracy of biopsy-based rejection diagnosis. RECENT FINDINGS: With advances in reducing immunological risk at transplantation and improved immunosuppression treatment renal allograft survival improved...
December 1, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/38032256/pushing-the-limits-of-treatment-for-hepatocellular-carcinoma
#25
JOURNAL ARTICLE
Michelle Jones-Pauley, David W Victor, Sudha Kodali
PURPOSE OF REVIEW: We review existing and newer strategies for treatment and surveillance of hepatocellular carcinoma (HCC) both pre and postliver transplantation. SUMMARY: HCC is rising in incidence and patients are often diagnosed at later stages. Consequently, there is a need for treatment strategies which include collaboration of multiple specialties. Combinations of locoregional, systemic, and surgical therapies are yielding better postliver transplantation (post-LT) outcomes for patients with HCC than previously seen...
December 1, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37922003/editorial-introductions
#26
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 1, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37909926/respiratory-viral-infections-including-covid-19-in-solid-organ-transplantation
#27
JOURNAL ARTICLE
Carson K L Lo, Deepali Kumar
PURPOSE OF REVIEW: Respiratory viral infections are prevalent and contribute to significant morbidity and mortality among solid organ transplant (SOT) recipients. We review updates from literature on respiratory viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in the SOT recipient. RECENT FINDINGS: With the wider availability and use of molecular diagnostic tests, our understanding of the epidemiology and impact of respiratory viruses in the SOT population continues to expand...
December 1, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37909925/expanding-indications-for-urogenital-transplantation-congenital-and-oncologic-defects-and-gender-affirmation
#28
JOURNAL ARTICLE
Christopher D Lopez, Alisa O Girard, Richard J Redett
PURPOSE OF REVIEW: Penile transplantation has become an emerging option for patients with severe genital defects. Only transplantation restores anatomy, sexual, and reproductive function of the penis. However, penile transplantation comes with important technical, psychosocial, ethical, and surgical challenges that must be considered for successful implementation. Indications for penile transplantation have yet to be clearly elucidated. RECENT FINDINGS: Since 2006, only five penile transplants have been performed globally...
December 1, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37811863/defining-chronic-rejection-in-vascularized-composite-allografts-do-we-have-reliable-surrogates-to-look-for
#29
REVIEW
Jean Kanitakis
PURPOSE OF REVIEW: Chronic rejection (CR) is a major threat in the field of vascularized composite tissue allografts (VCAs) as it causes graft dysfunction and usually graft loss. Unfortunately, knowledge of CR in VCA is incomplete because of the limited number of VCA recipients, the heterogeneous nature of VCAs and the short follow-up. RECENT FINDINGS: The diagnosis of CR in VCA has relied on clinical and pathological findings. Clinical changes include graft fibrosis, dyschromia and ischemic/necrotic ulcerations...
December 1, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37791523/transplant-tourism-a-missed-opportunity
#30
REVIEW
Hadar Merhav
PURPOSE OF REVIEW: To explore the resurgence of transplant tourism (TT) despite the recent reiteration of the Declaration of Istanbul (DoI) in 2018. As demand grows exponentially and supply remains static, novel approaches to bridging the gap should be explored. RECENT FINDINGS: TT is estimated to comprise up to 10% of transplants worldwide. Prosecuting patients seeking organs through TT has been unsuccessful. Extra jurisdictional prosecution of brokers, vendors and institutions participating in illicit TT has been difficult...
December 1, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37706301/improving-liver-transplant-outcomes-with-transplant-omics-and-network-biology
#31
REVIEW
Joseph Scarpa
PURPOSE OF REVIEW: Molecular omics data is increasingly ubiquitous throughout medicine. In organ transplantation, recent large-scale research efforts are generating the 'transplant-ome' - the entire set of molecular omics data, including the genome, transcriptome, proteome, and metabolome. Importantly, early studies in anesthesiology have demonstrated how perioperative interventions alter molecular profiles in various patient populations. The next step for anesthesiologists and intensivists will be to tailor perioperative care to the transplant-ome of individual liver transplant patients...
December 1, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37678396/living-liver-donor-pain-management
#32
REVIEW
Ryung A Kang, Justin Sangwook Ko
PURPOSE OF REVIEW: Optimal pain control in living liver donors undergoing hepatectomy is strongly recommended considering their unique status as healthy individuals willingly undergoing surgery for the benefit of the recipient. This review aims to examine and evaluate different strategies aimed at ensuring effective postoperative pain management in living liver donors. RECENT FINDINGS: Enhanced recovery after surgery (ERAS) protocols have proven effective in optimizing patient outcomes, including in living liver donor hepatectomy...
December 1, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37995156/cardiac-evaluation-of-the-liver-transplant-candidate
#33
JOURNAL ARTICLE
Stephen Possick, Vandana Khungar, Ranjit Deshpande
PURPOSE OF REVIEW: This review aims to summarize recent changes in the cardiac evaluation of adult liver transplant candidates. Over the last several years, there have been significant advances in the use of coronary computed tomography angiography (CCTA) with and without fractional flow reserve (FFR) and increasingly widespread availability of coronary calcium scoring for risk stratification for obstructive coronary artery disease. This has led to novel strategies for risk stratification in cirrhotic patients being considered for liver transplant and an updated American Heart Association (AHA) position paper on the evaluation of liver and kidney transplant candidates...
November 24, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37991065/regulatory-dendritic-cell-therapy-in-organ-transplantation
#34
JOURNAL ARTICLE
Yannis Hadjiyannis, Angus W Thomson
PURPOSE OF REVIEW: Regulatory dendritic cells (DCregs; also 'tolerogenic DCs'), innate immune cells that regulate the alloimmune response, are a novel cellular therapy for organ transplantation. Preliminary results from early-phase clinical trials in live donor kidney and liver transplantation are promising. This follows many years of research elucidating mechanisms of action and utility of DCregs. Herein, we review early-phase clinical trial observations and recent advances in the production, modification, and future-trajectory of DCreg in organ transplantation...
November 23, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37991047/controlling-infections-in-hospitalized-pretransplant-candidates
#35
JOURNAL ARTICLE
Marian G Lacy, Evgenii Filippov, Saman Nematollahi
PURPOSE OF REVIEW: Infections in hospitalized patients awaiting solid organ transplantation can pose complicated diagnostic and therapeutic challenges. Goals of management include stabilizing the patient, treating or controlling infections, and decreasing the risk of reactivation of infection after transplant. RECENT FINDINGS: Groups such as The Organ Procurement and Transplantation Network, American Society of Transplantation Infectious Diseases Community of Practice and the European Society of Clinical Microbiology and Infectious Diseases have updated their guidelines on screening and treatment of infection in transplant candidates...
November 15, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37851086/treating-rare-tumors-with-liver-transplantation
#36
JOURNAL ARTICLE
Andrew Melehy, Vatche Agopian
PURPOSE OF REVIEW: The success of liver transplantation (LT) in treating unresectable hepatocellular carcinoma (HCC) has resulted in interest in LT for other oncologic conditions. Here, we discuss the role of LT for rare oncologic indications including metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs), hepatic epitheliod hemangioendothelioma (HEHE), fibrolamellar hepatocellular carcinoma (FLC), and hepatic angiosarcoma (HAS). RECENT FINDINGS: Conditions reviewed have been documented indications for LT in the available literature...
October 19, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37823760/current-opinion-advances-in-machine-perfusion-and-preservation-of-vascularized-composite-allografts-will-time-still-matter
#37
JOURNAL ARTICLE
Tessa E Muss, Amanda H Loftin, Byoung Chol Oh, Gerald Brandacher
PURPOSE OF REVIEW: A major hurdle hindering more widespread application of reconstructive transplantation is the very limited cold ischemia time (CIT) of vascularized composite allografts (VCAs). In this review, we discuss cutting edge machine perfusion protocols and preservation strategies to overcome this limitation. RECENT FINDINGS: Several preclinical machine perfusion studies have demonstrated the multifactorial utility of this technology to extend preservation windows, assess graft viability prior to transplantation and salvage damaged tissue, yet there are currently no clinically approved machine perfusion protocols for reconstructive transplantation...
October 13, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37823752/optimizing-the-pediatric-transplant-candidate
#38
JOURNAL ARTICLE
James E Squires, Vikram K Raghu, George V Mazariegos
PURPOSE OF REVIEW: Advances in pediatric transplant parallel those in adult populations; however, there remain critical unique considerations and differences that require specialized knowledge and a specific skill set to optimize care afforded to the pediatric transplant candidate. We introduce general themes regarding optimization of the transplant candidate that are unique to children. RECENT FINDINGS: The pathologies leading to pediatric organ transplant candidacy differ from adults and a precise understanding of the physiologies and natural histories of such diseases is critical for optimized care...
October 13, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37800652/novel-cell-based-strategies-for-immunomodulation-in-vascularized-composite-allotransplantation
#39
JOURNAL ARTICLE
Maria Siemionow, Yalcin Kulahci, Fatih Zor
PURPOSE OF REVIEW: Vascularized composite allotransplantation (VCA) has become a clinical reality in the past two decades. However, its routine clinical applications are limited by the risk of acute rejection, and the side effects of the lifelong immunosuppression. Therefore, there is a need for new protocols to induce tolerance and extend VCA survival. Cell- based therapies have emerged as an attractive strategy for tolerance induction in VCA. This manuscript reviews the current strategies and applications of cell-based therapies for tolerance induction in VCA...
October 7, 2023: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/37859507/editorial-introductions
#40
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
October 1, 2023: Current Opinion in Organ Transplantation
journal
journal
32901
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.